Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Study highlights the efficacy and safety of tildrakizumab in improving physical, psychological, and social aspects of quality ...

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Plaque Psoriasis BURLINGAME, CA, UNITED STATES, January 27, 2025 /EINPresswire / -- The worldwide Plaque Psoriasis <a target=_blank href=h ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...

Medically reviewed by Arno Kroner, DAOM Cupping is a complementary therapy that involves suctioning the skin with cups made ...

Out of more than 3,000 skin diseases, how do you know what condition you have? These 23 skin rash pictures and expert tips ...